• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞病毒暴露与肾移植后总感染风险:病毒复制所致间接效应的队列研究。

Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication.

机构信息

Unit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.

Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas, Madrid, Spain.

出版信息

Transpl Int. 2022 Jan 20;35:10273. doi: 10.3389/ti.2021.10273. eCollection 2021.

DOI:10.3389/ti.2021.10273
PMID:35185374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8842254/
Abstract

Previous reports hypothesized that cytomegalovirus (CMV) may predispose to non-CMV infection after kidney transplantation (KT). We analysed the incidence of non-CMV infection (overall, bacterial and opportunistic) in 291 KT recipients according to the previous development of any level or high-level (≥1,000 IU/ml) CMV viremia. Exposure to CMV replication was assessed throughout fixed intervals covering first the 30, 90, 180 and 360 post-transplant days (cumulative exposure) and non-overlapping preceding periods (recent exposure). Adjusted Cox models were constructed for each landmark analysis. Overall, 67.7 and 50.5% patients experienced non-CMV and CMV infection, respectively. Patients with cumulative CMV exposure had higher incidence of non-CMV infection beyond days 30 (-value = 0.002) and 90 (-value = 0.068), although these associations did not remain after multivariable adjustment. No significant associations were observed for the remaining landmark models (including those based on high-level viremia or recent CMV exposure), or when bacterial and opportunistic infection were separately analysed. There were no differences in viral kinetics (peak CMV viremia and area under curve of CMV viral load) either. Our findings do not support the existence of an independent association between previous CMV exposure and the overall risk of post-transplant infection, although results might be affected by power limitations.

摘要

先前的报告假设巨细胞病毒(CMV)可能使肾移植(KT)后发生非 CMV 感染的风险增加。我们根据任何水平或高水平(≥1,000 IU/ml)CMV 病毒血症的先前发展,分析了 291 例 KT 受者中非 CMV 感染(整体、细菌和机会性)的发生率。通过在移植后第 30、90、180 和 360 天(累积暴露)和非重叠的先前时期(最近暴露)的固定间隔内评估 CMV 复制的暴露情况。为每个里程碑分析构建了调整后的 Cox 模型。总体而言,分别有 67.7%和 50.5%的患者经历了非 CMV 和 CMV 感染。具有累积 CMV 暴露的患者在第 30 天(-值 = 0.002)和第 90 天(-值 = 0.068)之后发生非 CMV 感染的发生率更高,但这些关联在多变量调整后并不存在。对于其余的里程碑模型(包括基于高水平病毒血症或最近 CMV 暴露的模型),或当单独分析细菌和机会性感染时,没有观察到显著的关联。病毒动力学(CMV 病毒血症峰值和 CMV 病毒载量曲线下面积)也没有差异。我们的研究结果不支持先前的 CMV 暴露与移植后感染的总体风险之间存在独立关联,尽管结果可能受到功效限制的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/aabf6fe3b902/ti-35-10273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/c5d04bbe6ee9/ti-35-10273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/f72185d7cb37/ti-35-10273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/1aa21222dab6/ti-35-10273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/aabf6fe3b902/ti-35-10273-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/c5d04bbe6ee9/ti-35-10273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/f72185d7cb37/ti-35-10273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/1aa21222dab6/ti-35-10273-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1fba/8842254/aabf6fe3b902/ti-35-10273-g004.jpg

相似文献

1
Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication.巨细胞病毒暴露与肾移植后总感染风险:病毒复制所致间接效应的队列研究。
Transpl Int. 2022 Jan 20;35:10273. doi: 10.3389/ti.2021.10273. eCollection 2021.
2
CMV infection, valganciclovir exposure, and the risk of BK viremia and associated nephropathy after kidney transplantation: Is there a link?巨细胞病毒感染、缬更昔洛韦暴露与肾移植后 BK 病毒血症及相关肾病的风险:二者是否存在关联?
Transpl Infect Dis. 2021 Aug;23(4):e13597. doi: 10.1111/tid.13597. Epub 2021 Mar 23.
3
Viral load kinetics and the clinical consequences of cytomegalovirus in kidney transplantation.病毒载量动力学与肾移植中巨细胞病毒的临床后果。
Front Immunol. 2024 Jan 31;14:1302627. doi: 10.3389/fimmu.2023.1302627. eCollection 2023.
4
Cytomegalovirus viremia after kidney transplantation in Thailand: predictors of symptomatic infection and outcome.泰国肾移植后巨细胞病毒血症:症状性感染的预测因素及结局
Transplant Proc. 2012 Apr;44(3):701-5. doi: 10.1016/j.transproceed.2011.12.029.
5
The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation.肾移植后病毒载量及巨细胞病毒复制开始时间对长期移植物存活的影响。
Antivir Ther. 2017;22(6):503-513. doi: 10.3851/IMP3129. Epub 2017 Jan 16.
6
Cytomegalovirus infection post-pancreas-kidney transplantation--results of antiviral prophylaxis in high-risk patients.巨细胞病毒感染胰腺-肾移植术后——高危患者抗病毒预防的结果。
Clin Transplant. 2013 Jul-Aug;27(4):503-9. doi: 10.1111/ctr.12138. Epub 2013 Jun 3.
7
Diagnostic utility of monitoring cytomegalovirus-specific immunity by QuantiFERON-cytomegalovirus assay in kidney transplant recipients.监测肾移植受者巨细胞病毒特异性免疫的诊断效用:QuantiFERON-cytomegalovirus assay。
BMC Infect Dis. 2018 Apr 16;18(1):179. doi: 10.1186/s12879-018-3075-z.
8
Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients.血清学阳性肾移植受者急性排斥反应治疗后的巨细胞病毒感染
Transpl Infect Dis. 2014 Jun;16(3):397-402. doi: 10.1111/tid.12227. Epub 2014 May 9.
9
[Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].[通过细胞因子流式细胞术监测肾移植受者中巨细胞病毒特异性CD4+和CD8+ T细胞反应]
Mikrobiyol Bul. 2016 Apr;50(2):224-35.
10
Choice of antibody immunotherapy influences cytomegalovirus viremia in simultaneous pancreas-kidney transplant recipients.抗体免疫疗法的选择会影响胰肾联合移植受者的巨细胞病毒血症。
Diabetes Care. 2006 Apr;29(4):842-7. doi: 10.2337/diacare.29.04.06.dc05-1647.

引用本文的文献

1
The Challenge of Bacterial Infections During Intensive Care Unit Stay After Heart Transplantation.心脏移植后重症监护病房住院期间细菌感染的挑战
Transpl Infect Dis. 2025 Apr 20;27(3):e70031. doi: 10.1111/tid.70031.

本文引用的文献

1
Effect of Preemptive Therapy vs Antiviral Prophylaxis on Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors: A Randomized Clinical Trial.抢先治疗与抗病毒预防对供体血清阳性受者血清阴性肝移植患者巨细胞病毒病的影响:一项随机临床试验。
JAMA. 2020 Apr 14;323(14):1378-1387. doi: 10.1001/jama.2020.3138.
2
A critical review of the relationship between post-transplant atherosclerotic events and cytomegalovirus exposure in kidney transplant recipients.肾移植受者移植后动脉粥样硬化事件与巨细胞病毒暴露之间关系的批判性回顾。
Expert Rev Anti Infect Ther. 2020 Feb;18(2):113-125. doi: 10.1080/14787210.2020.1707079. Epub 2019 Dec 25.
3
Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients.
提高我们对移植受者中 CMV 感染间接影响的机制理解。
Am J Transplant. 2019 Sep;19(9):2495-2504. doi: 10.1111/ajt.15371. Epub 2019 Apr 23.
4
Risk of opportunistic infection in kidney transplant recipients with cytomegalovirus infection and associated outcomes.肾移植受者巨细胞病毒感染的机会性感染风险及相关结局。
Transpl Infect Dis. 2019 Jun;21(3):e13080. doi: 10.1111/tid.13080. Epub 2019 Apr 16.
5
BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.BK 多瘤病毒在实体器官移植中的作用——美国移植感染病学会实践社区指南。
Clin Transplant. 2019 Sep;33(9):e13528. doi: 10.1111/ctr.13528. Epub 2019 Apr 10.
6
A Multicenter Case-control Study of the Effect of Acute Rejection and Cytomegalovirus Infection on Pneumocystis Pneumonia in Solid Organ Transplant Recipients.多中心病例对照研究急性排斥反应和巨细胞病毒感染对实体器官移植受者肺囊虫肺炎的影响。
Clin Infect Dis. 2019 Apr 8;68(8):1320-1326. doi: 10.1093/cid/ciy682.
7
Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials.用于临床试验的移植患者巨细胞病毒感染和疾病的定义。
Clin Infect Dis. 2017 Jan 1;64(1):87-91. doi: 10.1093/cid/ciw668. Epub 2016 Sep 28.
8
Management of cytomegalovirus infection in solid organ transplant recipients: SET/GESITRA-SEIMC/REIPI recommendations.实体器官移植受者巨细胞病毒感染的管理:SET/GESITRA-SEIMC/REIPI建议
Transplant Rev (Orlando). 2016 Jul;30(3):119-43. doi: 10.1016/j.trre.2016.04.001. Epub 2016 Apr 29.
9
Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.肾移植受者侵袭性肺曲霉病的临床表现和死亡决定因素:一项多国队列研究。
Am J Transplant. 2016 Nov;16(11):3220-3234. doi: 10.1111/ajt.13837. Epub 2016 May 31.
10
Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation.巨细胞病毒感染对心脏移植后心脏移植血管病变发展的影响。
J Heart Lung Transplant. 2015 Aug;34(8):1112-9. doi: 10.1016/j.healun.2015.03.015. Epub 2015 Mar 26.